CONGENITAL ADRENAL HYPERPLASIA: CALCIUM CHANNELS AS THERAPEUTIC TARGETS

先天性肾上腺增生：钙通道作为治疗目标

• 批准号: 7377449
• 负责人: KAREN J LOECHNER
• 金额: $ 0.57万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377449
• 关键词: CONGENITAL; ADRENAL; HYPERPLASIA; CALCIUM; CHANNELS

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will test the ability of amlodipine, a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication currently taking to treat CAH

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。这项研究将测试降血压药物降血糖的能力，以减少目前用于治疗CAH的糖皮质激素药物的剂量